0001127602-12-013635.txt : 20120411 0001127602-12-013635.hdr.sgml : 20120411 20120411163125 ACCESSION NUMBER: 0001127602-12-013635 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120409 FILED AS OF DATE: 20120411 DATE AS OF CHANGE: 20120411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAVIDAS ATHANESE CENTRAL INDEX KEY: 0001264778 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12754541 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-04-09 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001264778 LAVIDAS ATHANESE C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 Common Stock 2012-04-09 4 S 0 15000 15.7567 D 115631 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 26, 2012. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.64 to $16.00, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-04-10